PvP Biologics
specializes in developing an oral enzyme for the treatment of celiac disease... Read morePvP Biologics
specializes in developing an oral enzyme for the treatment of celiac disease... Read more
News
Apr 09, 2020
GeekWire
PvP Biologics: After buying Seattle startup PvP Biologics for $330M, Takeda to advance celiac disease treatment
Mar 10, 2020
The Business Journals: Sacramento
PvP Biologics: UC Davis professor's gluten treatment company sells for up to $330 million
Mar 08, 2020
San Diego Business Journal
PvP Biologics: PvP Deal Could Be Worth More Than $330M
Mar 03, 2020
Contract Pharma
PvP Biologics: Takeda Acquires PvP Biologics
Feb 28, 2020
Medical Buyer
PvP Biologics: Takeda Takes Aim At Becoming World Leader In Treating Celiac & Other GI Disorders
Feb 27, 2020
St Louis Post Dispatch
PvP Biologics: Takeda Pharmaceuticals buys San Diego biotech for $330M to enhance drug pipeline for celiac disease
Feb 26, 2020
PMLiVE
PvP Biologics: Takeda buys coeliac disease partner PvP Biologics after phase 1 win
Feb 26, 2020
BioPharma Dive
PvP Biologics: Takeda's small celiac disease bet turns into acquisition
May 21, 2019
GeekWire
PvP Biologics: How a hamburger and milkshake from Dick's Drive-In led to a breakthrough for this biotech startup
Sep 07, 2018
Beckers ASC Review
PvP Biologics: PvP Biologics begins 1st in-human celiac disease trials - 4 insights
PvP Biologics Competitors
1
2
3
4
5
6
7
8
9
10